Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
3.880
-0.190 (-4.67%)
Streaming Delayed Price
Updated: 11:09 AM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
22
23
Next >
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 20, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These
↗
December 19, 2024
These windows of opportunity aren't likely to remain open for much longer.
Via
The Motley Fool
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
↗
December 17, 2024
Via
The Motley Fool
Prediction: This Stock Will Beat the Market in 2025
↗
December 12, 2024
Via
The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
↗
December 07, 2024
Just be ready to ride out some inevitable turbulence along the way.
Via
The Motley Fool
Peering Into Iovance Biotherapeutics's Recent Short Interest
↗
December 05, 2024
Via
Benzinga
Is Iovance Biotherapeutics Stock a Millionaire Maker?
↗
November 27, 2024
Via
The Motley Fool
Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
↗
November 23, 2024
Via
The Motley Fool
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
November 26, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
↗
November 25, 2024
Via
Benzinga
2 Innovative Stocks That Could Deliver Outsize Returns
↗
November 22, 2024
Via
The Motley Fool
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
↗
November 16, 2024
Via
The Motley Fool
A Peek at Iovance Biotherapeutics's Future Earnings
↗
November 06, 2024
Via
Benzinga
Is Iovance Biotherapeutics Stock a Buy?
↗
October 04, 2024
The biotech is making important breakthroughs, but is that enough?
Via
The Motley Fool
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
↗
September 03, 2024
Via
Benzinga
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
November 07, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
October 31, 2024
Iovance also to Participate in Upcoming November Conferences
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Why Iovance Biotherapeutics Stock Triumphed on Thursday
↗
October 24, 2024
With a cutting-edge melanoma drug now on the market, the company is positioned for a breakout.
Via
The Motley Fool
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
↗
September 26, 2024
This biotech's growth story is going to start moving faster, and soon.
Via
The Motley Fool
Looking Into Iovance Biotherapeutics's Recent Short Interest
↗
August 16, 2024
Via
Benzinga
Iovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
↗
August 12, 2024
Via
Benzinga
3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
↗
September 16, 2024
There's plenty of upside with this stock, but it might take a while to realize.
Via
The Motley Fool
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
↗
September 08, 2024
The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.
Via
Benzinga
Topics
Artificial Intelligence
This Is the Biggest Risk With Iovance Biotherapeutics Stock
↗
September 06, 2024
Investors should brace for dilution.
Via
The Motley Fool
Iovance Biotherapeutics to Present at Upcoming Conferences
September 03, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Monster Biotech Stocks to Buy Before 2025
↗
September 02, 2024
These companies are nearly in the sweet spot of risk versus reward in biotech.
Via
The Motley Fool
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
↗
August 27, 2024
This company's new cancer therapy is producing remarkable results, but the company is losing money at a frightening pace.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 16, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
↗
August 14, 2024
It could demonstrate a few capabilities that no other biotech has as of yet.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 12, 2024
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
